With a stake in two post-acute care companies under its belt, health insurer Humana saw its share price hit a new record high last week.

Adam Boehler, the director of the Center for Medicare & Medicaid Innovation (CMMI), has been appointed to serve as a senior adviser to for HHS’s Value-Based Transformation and Innovation.

Retail giant Amazon is in early talk to invest in Medplus, India’s second-largest pharmacy chain, according to FactorDaily.

Sentiments in the notes of ICU nurses are good indicators of whether patients will survive, according to researchers from the University of Waterloo in Ontario, Canada.

President Donald Trump’s policy of “zero tolerance” on illegal immigration has led HHS to redirect millions in funding to house migrant children separated from their parents at the border.

Artificial intelligence (AI) is proving valuable across the healthcare spectrum—from helping radiologists screen for disease to predicting difficulties during surgery. Researchers now hope the cutting-edge technology could safeguard public health by monitoring large-scale water treatment operations.

Proposed changes to the 340B drug pricing program, in addition to other cuts in payments, are being called out by industry associations and providers.

Speeding up the regulatory process has led to uncertainty about the effectiveness of some new drugs.

Major healthcare organizations, including branches of the National Institutes of Health (NIH), have launched a $26.5 million study to investigate the genetic and socioeconomic factors surrounding black men’s increased susceptibility to more aggressive forms of prostate cancer, according to an NIH release.

The Federal Communications Commission (FCC) is planning to launch a new $100 million telehealth initiative called the Connected Care Pilot Program.